A study from New York University Langone Medical Center, published in JAMA Psychiatry in January 2021, revealed that people living with schizophrenia who contracted Covid-19 were 2.7 times more likely to die than those without psychiatric illness — a risk surpassed only by age itself. Drawing on nearly 7,400 cases across New York's first pandemic wave, researchers found no direct biological mechanism to explain the disparity, pointing instead toward something older and more troubling: a healthcare system that has long failed its most vulnerable. The virus did not single out schizophrenia — it
ThePrint
· Jan 30, 2021
· health
· 3 min read
High
Sourcing: Verified
Schizophrenia linked to 2.7x higher Covid mortality risk, second only to age
Schizophrenia patients with Covid-19 faced significantly elevated mortality risk, with 75 affected individuals among 7,348 positive cases studied in New York.
◉
Health & Medicine
8412 related articles
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% match
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% match
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% match
Related Coverage
BBC News · Aug 25
School asbestos exposure linked to woman's death at 46, family claims
A woman died from mesothelioma at 46, likely exposed to asbestos at her Cardiff school decades earlier. Her family is su…
Future of Personal Health - · Aug 25 NGS Technology Transforms Uncertain Infections Into Actionable DiagnosesHybrid-capture NGS technology helps clinicians identify pathogens in diagnostically challenging cases by simultaneously …
The Guardian · Aug 25 Shark attack survivor Leah Stewart recalls 'monster' in first interview since losing armLeah Stewart, who lost her arm in a June shark attack at Coogee Beach, recalls the traumatic encounter in her first inte…
Education News Canada · Aug 25 Systemic racism, restrictive policies block Black Canadians from blood donationBlack Canadians face systemic barriers to blood donation despite critical need for ethnicity-matched blood for sickle ce…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
🌎
Medical research finding on psychiatric comorbidity and COVID mortality has no direct geopolitical implications; this is a public health/epidemiological study.
Escalation Risk
low
Confidence
HIGH
Economic Lens
📈
Schizophrenia identified as second-highest Covid-19 mortality risk factor after age (2.7x higher death risk), with significant implications for healthcare resource allocation and mental health service capacity.
Market Signal
mixed
Confidence
HIGH
Healthcare and Hospitals
Mental Health Services
Pharmaceutical and Biotech
Insurance and Health Coverage
Long-term Care Facilities
Individuals with schizophrenia face substantially elevated healthcare costs, insurance premiums, and need for specialized Covid-19 treatment protocols. Households with affected members may experience increased out-of-pocket expenses and reduced workforce participation due to health complications.
Governments likely to prioritize schizophrenia patients in vaccination campaigns and Covid-19 treatment access; mental health services funding may increase; healthcare systems may require enhanced psychiatric-medical integration; insurance regulations may need adjustment for pre-existing psychiatric conditions; workplace accommodations and disability support programs may expand.